Last 450.45 INR
Change Today -5.95 / -1.30%
Volume 4.6K
SEQ On Other Exchanges
Symbol
Exchange
Mumbai
As of 6:21 AM 09/19/14 All times are local (Market data is delayed by at least 15 minutes).

sequent scientific ltd (SEQ) Snapshot

Open
460.00
Previous Close
456.40
Day High
469.00
Day Low
436.00
52 Week High
09/11/14 - 507.95
52 Week Low
12/6/13 - 125.00
Market Cap
12.3B
Average Volume 10 Days
47.3K
EPS TTM
-42.76
Shares Outstanding
27.3M
EX-Date
09/16/11
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for SEQUENT SCIENTIFIC LTD (SEQ)

Related News

No related news articles were found.

sequent scientific ltd (SEQ) Related Businessweek News

No Related Businessweek News Found

sequent scientific ltd (SEQ) Details

SeQuent Scientific Limited operates as an integrated pharmaceutical company in India and internationally. It produces human and animal health active pharmaceutical ingredients (APIs). The company’s human APIs portfolio covers anti-malarial, anthelmintic, anti-infective, antiviral, niche CVS, CNS, and dermatology therapeutic segments; and animal health APIs covers anthelmintic, antiprotozoal, nutraceutical, NSAID, anti-infective, dermatology, and other therapeutic segments. The company also provides specialized analytical solutions to technical and regulatory problems. It also manufactures a range of veterinary products in finished dosage form for use in the therapeutic category. In addition, the company provides contract research and custom synthesis, contract manufacturing, and custom process development services, as well as specialty chemicals for various industries. The company was formerly known as PI Drugs and Pharmaceuticals Limited and changed its name to SeQuent Scientific Limited in October 2009. SeQuent Scientific Limited was incorporated in 1985 and is headquartered in Bengaluru, India.

1,100 Employees
Last Reported Date: 09/8/14
Founded in 1985

sequent scientific ltd (SEQ) Top Compensated Officers

Joint Managing Director, Executive Director, ...
Total Annual Compensation: 12.5M
Compensation as of Fiscal Year 2014.

sequent scientific ltd (SEQ) Key Developments

Sequent Scientific Ltd. Reports Unaudited Consolidated Earnings Results for the First Quarter Ended June 30, 2014

Sequent Scientific Ltd. reported unaudited consolidated earnings results for the first quarter ended June 30, 2014. For the quarter, the company's EBITDA was INR 74 million against INR 58 million a year ago. The company's revenues were INR 1,127 million. The company reported 27% increase in operating profits during the quarter.

Sequent Scientific Ltd. to Report Q1, 2015 Results on Aug 13, 2014

Sequent Scientific Ltd. announced that they will report Q1, 2015 results on Aug 13, 2014

Sequent Scientific Ltd., Board Meeting, Aug 13, 2014

Sequent Scientific Ltd., Board Meeting, Aug 13, 2014. Agenda: To consider the un-audited financial results of the company for the quarter ended June 30, 2014.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
SEQ:IN 450.45 INR -5.95

SEQ Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for SEQ.
View Industry Companies
 

Industry Analysis

SEQ

Industry Average

Valuation SEQ Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 2.7x
Price/Book 21.0x
Price/Cash Flow NM Not Meaningful
TEV/Sales 1.6x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact SEQUENT SCIENTIFIC LTD, please visit www.sequent.in. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.